APA (7th ed.) Citation

Alan Faraj, Tom Knudsen, Shraddha Desai, Linda Neuman, Grant E. Blouse, & Ulrika S. H. Simonsson. (2022). Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug. Wiley.

Chicago Style (17th ed.) Citation

Alan Faraj, Tom Knudsen, Shraddha Desai, Linda Neuman, Grant E. Blouse, and Ulrika S. H. Simonsson. Phase III Dose Selection of Marzeptacog Alfa (activated) Informed by Population Pharmacokinetic Modeling: A novel Hemostatic Drug. Wiley, 2022.

MLA (9th ed.) Citation

Alan Faraj, et al. Phase III Dose Selection of Marzeptacog Alfa (activated) Informed by Population Pharmacokinetic Modeling: A novel Hemostatic Drug. Wiley, 2022.